{"auto_keywords": [{"score": 0.050077251772678626, "phrase": "patent_performance"}, {"score": 0.043577967193920215, "phrase": "corporate_performance"}, {"score": 0.04085725577019767, "phrase": "patent_h_index"}, {"score": 0.03668160968875943, "phrase": "epi"}, {"score": 0.00470862827326028, "phrase": "corporation_performance"}, {"score": 0.00445293569103488, "phrase": "panel_regression_model"}, {"score": 0.003808209866576388, "phrase": "current_impact_index"}, {"score": 0.003561205990687285, "phrase": "essential_patent_index"}, {"score": 0.0033301694494391643, "phrase": "pharmaceutical_company"}, {"score": 0.002977835845437357, "phrase": "positive_influences"}, {"score": 0.002574788013427524, "phrase": "pharmaceutical_companies"}, {"score": 0.0021049977753042253, "phrase": "elsevier_ltd."}], "paper_keywords": ["Patent citations", " H index", " Essential patent index", " Current impact index"], "paper_abstract": "This study utilizes panel regression model to explore the relationships between corporate performance and the patent performance measured from patent H index, current impact index (CII), and essential patent index (EPI) in the pharmaceutical company. The results demonstrate that patent H index and EPI have positive influences upon corporate performance. Furthermore, this study developed a classification for the pharmaceutical companies to divide them into four types, and provided some suggestions to them. (C) 2011 Elsevier Ltd. All rights reserved.", "paper_title": "The relationships between the patent performance and corporation performance", "paper_id": "WOS:000298325300016"}